Repligen Corporation (RGEN) Competitors & Peers
The 5 largest companies in the same industry as Repligen Corporation, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| ISRG | Peer | $452.80 | P/E 54.8RSI 57Cap 160.4 B |
| MDLN | Peer | $39.64 | P/E 90.1RSI 69Cap 34.8 B |
| BDX | Peer | $211.88 | P/E 41.9RSI 75Cap 57.7 B |
| ALC | Peer | $74.94 | P/E 56.8RSI 66Cap 36.5 B |
| WST | Peer | $399.81 | P/E 44.9RSI 58Cap 28.2 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- PFESupplier
Own 10-Q customer-concentration disclosure: Pfizer = 11% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - GESupplier
Own 10-K customer-concentration disclosure: GeneralElectricHealthcare = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - BMRNSupplier
Own 10-Q customer-concentration disclosure: BiomarinPharmaceuticalIncorporated = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - DHRSupplier
Own 10-Q customer-concentration disclosure: Cytiva = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗